NCT02808416 - Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

June 30, 2019

Conditions

Brain CancerNeoplasm Metastases

Interventions

BIOLOGICAL

Personalized cellular vaccine

"Cancer patients with brain metastases will undergo tumor resection or biopsy, and receive tumor antigen mRNA pulsed cellular vaccines.~Other Names:~• Tumor antigen pulsed DC and PBMC, autologous tumor vaccine"

Trial Locations (1)

Unknown

Guangdong 999 Brain Hospital, Guangzhou